Green tea extract prevents hepatitis C virus from entering the liver

According to the latest report of the times of India, a new German study published in the latest hepatology found that a kind of flavone in green tea can inhibit the entry of hepatitis C virus (HVC) into the liver According to the latest research of Hanover Medical College in Germany, EGCG, an extract of green tea, has antiviral effect and can prevent hepatitis C virus infection after liver transplantation According to the World Health Organization statistics, hepatitis C virus infection can lead to chronic hepatitis, cirrhosis and liver cell carcinoma (HCC) or fatal liver cancer Hepatitis C virus is one of the main causes of chronic liver disease, and also one of the key indications of liver transplantation There are 170 million people infected with hepatitis C virus in the world The researchers say the current standard treatment for hepatitis C involves interferon ribavirin and new HVC protease inhibitors, which can clear the hepatitis C virus in some patients, but have no effect on a large number of patients In addition, the reinfection of HCV to healthy donor liver in patients receiving liver transplantation is also of great concern The timely implementation of antiviral measures after liver transplantation to prevent HCV reinfection is an important measure to improve the survival rate and quality of life of patients Dr Sandra sisek and Dr EK Steinman studied the effect of EGCG on preventing hepatitis C virus from attaching to liver cells According to Dr sisek, EGCG and other green tea catechins and their derivatives, such as gallic catechins (EGC), epicatechin (ECG) and epicatechin (EC), have antiviral and anticancer properties The new study further explored the potential role of these flavonoids in preventing HCV reinfection after liver transplantation The results showed that EGCG, unlike other catechin derivatives, could prevent HCV from entering liver cells.